- Report
- January 2026
- 380 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 152 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 376 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 588 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 282 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 216 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 148 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 196 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 193 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 132 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 474 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 178 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 180 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 246 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 683 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 196 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- January 2026
- 272 Pages
Global
From €5177EUR$5,850USD£4,506GBP
- Report
- May 2025
- 154 Pages
Global
From €4203EUR$4,750USD£3,659GBP
- Report
- May 2025
- 115 Pages
Global
From €4203EUR$4,750USD£3,659GBP
- Report
- May 2025
- 114 Pages
Global
From €4203EUR$4,750USD£3,659GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more